We serve Chemical Name:4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid CAS:105356-71-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid
CAS.NO:105356-71-6
Synonyms:Benzenebutanoicacid,4-(1H-imidazol-1-yl)-a,g-dioxo;GL-0061;2,4-DIBROMOBENZYL ALCOHOL
Molecular Formula:C13H10N2O4
Molecular Weight:258.22900
HS Code:2933290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:292.1ºC at 760 mmHg
Density:1.16 g/cm3
Index of Refraction:1.633
PSA:89.26000
Exact Mass:258.06400
LogP:1.09880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzenebutanoicacid,4-(1H-imidazol-1-yl)-a,g-dioxo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-DIBROMOBENZYL ALCOHOL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-DIBROMOBENZYL ALCOHOL Use and application,Benzenebutanoicacid,4-(1H-imidazol-1-yl)-a,g-dioxo technical grade,usp/ep/jp grade.
Related News: Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain. 4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid manufacturer A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan. 4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid supplier The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. 4-(4-imidazol-1-ylphenyl)-2,4-dioxobutanoic acid factory Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes.
